Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune-remodeling mRNAs expressing IRF8 or NIK generate durable antitumor immunity in multiple cancer models.

Nature biotechnology·2026
Same author

Erasable FAP Targeted Spray-On Probe for Fluorescence-Guided Surgery.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Integrated Multi-Channel Automatic Cellular Profiling (iMAP) System for Cholangiocarcinoma Diagnosis.

Small (Weinheim an der Bergstrasse, Germany)·2025
Same author

Therapeutic Targeting of Epithelial-Mesenchymal Cellular Plasticity in Pancreatic Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Targeting cancer-associated fibroblasts for real-time intraoperative tumor identification with a spray-on fluorescent probe.

Science advances·2025
Same author

Far-Red Spray-On Imaging Probes for FAP-Targeted Cancer Surgery.

Bioconjugate chemistry·2025
Same journal

Overcoming the Catalytic Bucket Effect in Pt-based High-Entropy Nanocages Through Interface Defect and Strain Engineering.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Rare-Earth-Sulfur Surface Modification Enables SiC Ceramics for Low-Frequency Electromagnetic Wave Absorption in Extreme Environments.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

PFKFB4 Deubiquitination by USP10 Enhances Fumarate Metabolism to Orchestrate the KDM1A/Rad51 Axis and Confer Radioresistance in Lung Cancer.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Assessing Strengths and Limitations of Magnetoencephalography Source Imaging With Intracerebral EEG.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Efficient Adsorption-Based Direct Air Capture Via Triply Periodic Minimal Surface Architectures.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Inhalable ROS-Responsive Nanospray Activates PPAR-γ to Restore Macrophage Mitochondrial Homeostasis and Attenuate Radiation-Induced Lung Injury.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
See all related articles

Related Experiment Video

Updated: Jul 14, 2025

Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation
08:08

Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation

Published on: July 8, 2011

20.5K

Hybrid LNP Prime Dendritic Cells for Nucleotide Delivery.

Riddha Das1, Elias A Halabi1, Ina R Fredrich1

  • 1Center for Systems Biology, Massachusetts General Hospital, 185 Cambridge St, CPZN 5206, Boston, MA, 02114, USA.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|October 9, 2023
PubMed
Summary
This summary is machine-generated.

New hybrid nanoparticles activate immune cells to eradicate tumors and establish lasting anti-tumor immunity. This dual-delivery system combines double-stranded RNA and an immune modulator for enhanced cancer vaccine strategies.

Keywords:
TLRcancerdendritic cellsnanoparticlesvaccine stimulant

More Related Videos

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

10.1K
Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

23.2K

Related Experiment Videos

Last Updated: Jul 14, 2025

Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation
08:08

Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation

Published on: July 8, 2011

20.5K
Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

10.1K
Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

23.2K

Area of Science:

  • Immunology
  • Nanotechnology
  • Oncology

Background:

  • Activation of dendritic cells (DCs) is crucial for cancer vaccines and direct anti-tumor effects.
  • Stimulating DCs effectively without causing toxicity remains a significant challenge.
  • Combinatorial approaches may reduce toxicity of TLR3 agonists while improving efficacy.

Purpose of the Study:

  • To develop and test a hybrid lipid nanoparticle (LNP) platform for co-delivery of double-stranded RNA (dsRNA) and an immune modulator.
  • To evaluate the anti-tumor efficacy and immune response generated by the hybrid LNP system in preclinical models.

Main Methods:

  • Development of hybrid nanoparticles-in-nanoparticles encapsulating dsRNA (polyinosinic:polycytidylic acid) and L-CANDI.
  • Administration of hybrid LNPs to mouse models with established tumors.
  • Assessment of tumor eradication, survival rates, and long-term anti-tumor immunity.

Main Results:

  • The hybrid LNP platform effectively eradicated established tumors in mouse models.
  • Treatment with hybrid nanoparticles generated durable, long-lasting anti-tumor immunity.
  • The nanoparticle system demonstrated potential for dose reduction of TLR3 agonists.

Conclusions:

  • Hybrid LNP platform enables efficient co-delivery of dsRNA and immune modulators.
  • This novel approach shows significant potential for cancer immunotherapy and vaccine development.
  • The findings support a combinatorial strategy for enhanced and safer cancer treatment.